Learn More
BACKGROUND A new botulinum neurotoxin type A formulation, abobotulinumtoxinA (BoNTA-ABO; Medicis Aesthetics Inc., Scottsdale, AZ), was approved in 2009 in the United States for treatment of moderate(More)
For many decades, chemical peeling has played an important role in facial rejuvenation. These procedures are safe and effective in the management of photoaging, scarring, pigmentary dyschromias, and(More)